Search Results - "McMillin, Douglas W"
-
1
Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
Published in Cancer research (Chicago, Ill.) (15-07-2009)“…The phosphatidylinositol 3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) pathway mediates proliferation, survival, and drug resistance in multiple…”
Get full text
Journal Article -
2
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia
Published in Blood (15-12-2007)“…Waldenstrom macroglobulinemia (WM) is an incurable low-grade lymphoplasmacytic lymphoma. We demonstrate up-regulated Akt activity in WM, and that Akt…”
Get full text
Journal Article -
3
The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
Published in Nature reviews. Drug discovery (01-03-2013)“…Key Points It is increasingly recognized that the tumour microenvironment has a crucial role in modulating tumour sensitivity to drugs. Stromal influence can…”
Get full text
Journal Article -
4
Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
Published in Clinical cancer research (01-12-2009)“…Purpose: p53 is inactivated in many human malignancies through missense mutations or overexpression of the human homologue of Mdm2 (Hdm2), an E3 ubiquitin…”
Get full text
Journal Article -
5
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma
Published in Haematologica (Roma) (01-08-2011)“…Isothiocyanates, a family of phytochemicals found in cruciferous vegetables, have cytotoxic effects against several types of tumor cells. Multiple myeloma is a…”
Get full text
Journal Article -
6
The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective Therapies
Published in Hematology/oncology clinics of North America (01-12-2007)“…Multiple myeloma (MM) is viewed as a prototypic disease state for the study of how neoplastic cells interact with their local bone marrow (BM)…”
Get full text
Journal Article -
7
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
Published in Molecular cancer therapeutics (01-05-2008)“…Clinical studies of patients with chronic myeloid leukemia revealed that a common pattern of response is a dramatic fall in the circulating population of blast…”
Get full text
Journal Article -
8
Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation
Published in PloS one (07-07-2011)“…Polo-like kinases (PLKs) play an important role in cell cycle progression, checkpoint control and mitosis. The high mitotic index and chromosomal instability…”
Get full text
Journal Article -
9
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells
Published in Molecular cancer therapeutics (01-07-2007)“…Members of the inhibitor of apoptosis protein (IAP) family play a role in mediating apoptosis. Studies suggest that these proteins may be a viable target in…”
Get full text
Journal Article -
10
Introduction to the “Has the Fed Failed?” Special Section
Published in Journal of macroeconomics (01-09-2012)Get full text
Journal Article -
11
Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ
Published in Journal of breast cancer (01-09-2012)“…Tumor-specific delivery of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), an apoptosis-inducing peptide, at effective doses remains…”
Get full text
Journal Article -
12
High-throughput approaches to discover novel immunomodulatory agents for cancer
Published in Oncoimmunology (01-11-2012)“…The clinical success of immunomodulatory thalidomide derivatives has renewed the general interest in immunomodulatory anticancer compounds and prompted us to…”
Get full text
Journal Article -
13
In vitro anti‐myeloma activity of the Aurora kinase inhibitor VE‐465
Published in British journal of haematology (01-12-2009)“…Summary This study characterized the preclinical anti‐myeloma activity of VE465, a low molecular weight pan‐Aurora kinase inhibitor. After 96‐h drug exposure,…”
Get full text
Journal Article -
14
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Published in Nature medicine (01-04-2010)“…McMillin et al . describe a drug screening platform that takes into account the tumor microenvironment, in particular tumor-stromal interactions, enabling the…”
Get full text
Journal Article -
15
Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Published in Nature medicine (01-04-2024)Get full text
Journal Article -
16
Nominal GDP versus price level targeting: An empirical evaluation
Published in Journal of economics and business (01-05-2020)“…•Two alternatives to inflation targeting are discussed.•Policy simulations of price level and nominal GDP targets are analyzed.•Loss functions comparing policy…”
Get full text
Journal Article -
17
Inhibition of Tumor Cells Interacting with Stromal Cells by Xanthones Isolated from a Costa Rican Penicillium sp
Published in Journal of natural products (Washington, D.C.) (27-04-2012)“…CR1642D, an endophytic isolate of Penicillium sp. collected from a Costa Rican rainforest, was identified through a high-throughput approach to identify…”
Get full text
Journal Article -
18
Discovery of a Potent, Covalent BTK Inhibitor for B‑Cell Lymphoma
Published in ACS chemical biology (16-05-2014)“…BTK is a member of the TEC family of non-receptor tyrosine kinases whose deregulation has been implicated in a variety of B-cell-related diseases. We have used…”
Get full text
Journal Article -
19
Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance
Published in Clinical cancer research (15-10-2013)“…Cellular immunotherapy frequently fails to induce sustained remissions in patients with multiple myeloma, indicating the ability of multiple myeloma cells to…”
Get full text
Journal Article -
20
Cross-Country Variation in the Liquidity Effect: The Role of Financial Markets
Published in The Economic journal (London) (01-10-2004)“…This paper examines cross-country variation in the liquidity effect - the negative response of interest rates to money supply shocks - focusing on the role of…”
Get full text
Journal Article